Tabula Rasa HealthCare, which provides e-prescription fulfillment and medication risk management services, raised $52 million by offering 4.3 million shares at $12, below the range of $13 to $15. Tabula Rasa HealthCare plans to list on the Nasdaq under the symbol TRHC. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as lead managers on the deal.
